LINC01221: A Protein Target for Cancer, Heart Disease, and Neurodegenerative Disorders

Target Name: LINC01221

NCBI ID: G104266961

LINC01221

Other Name(s): TCONS_00000366 | Long intergenic non-protein coding RNA 1221 | long intergenic non-protein coding RNA 1221

LINC01221: A Protein Target for Cancer, Heart Disease, and Neurodegenerative Disorders

LINC01221 (TCONS-00000366) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the TCON (transmembrane conformation) family of proteins, which are known for their ability to form tight junctions, which are a type of cell-cell barrier.

The TCON family of proteins is important for many different functions in the body, including the regulation of cell signaling pathways and the maintenance of tissue structure. LINC01221 is specifically involved in the regulation of the Shh (signaling homeodetic) gene, which is responsible for promoting the formation of tissues and organs during development.

LINC01221 has also been shown to play a role in the regulation of the Wnt (Wnt signaling) pathway, which is involved in the development and maintenance of tissues and organs. The Wnt pathway is a critical regulator of cell signaling during development, and LINC01221 has been shown to play a role in the regulation of Wnt signaling by the Shh gene.

In addition to its role in the regulation of the Wnt pathway, LINC01221 has also been shown to be involved in the regulation of many other signaling pathways, including the NF-kappa (transforming growth factor-??) pathway, the FGF (fibroblast growth factor) pathway, and the NF-kappa-B (nuclear factor kappa B) pathway.

The discovery of LINC01221 as a potential drug target is significant because it represents a new approach to treating a wide range of diseases. Many diseases, including cancer, heart disease, and neurodegenerative disorders, are caused by the disruption of normal cell signaling pathways. By targeting LINC01221, researchers may be able to develop new treatments that can restore the balance of cell signaling pathways and improve the health and well-being of many individuals.

In conclusion, LINC01221 is a protein that is expressed in various tissues of the body and is involved in the regulation of many different signaling pathways. Its potential as a drug target makes it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of LINC01221 in cell signaling and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 1221

The "LINC01221 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01221 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets